Tag: Prota
Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments
MELBOURNE, Jan 16, 2024 – (ACN Newswire) – Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, today announced financing of US$21 million in equity and debt financing. The round, led by Singapore-based SPRIM Global Investments (SGI), will help the company prepare for a Phase 3 clinical investigation of the company’s PRT120 oral therapy for peanut allergy. “SPRIM brings valuable expertise, capabilities and an international investment network to Prota’s technology and clinical program,” said Prota Executive Chairman Kelly Constable. “This partnership and funding will accelerate Prota’s drug development ... Read more